GSDMD and inflammatory bowel disease: Bulek et al. (2020) also showed that GSDMD deficiency considerably decreases the severity of the disease, relating to the GSDMD-mediated release of IL-1β sEVs in the intestinal inflammation pathogenesis, as observed in IBD [67].